{"id":6090,"date":"2020-02-15T11:09:17","date_gmt":"2020-02-15T10:09:17","guid":{"rendered":"https:\/\/www.fondazioneartet.it\/?p=6090"},"modified":"2020-07-19T20:12:32","modified_gmt":"2020-07-19T18:12:32","slug":"venous-thromboembolism-prevention-and-treatment","status":"publish","type":"post","link":"https:\/\/www.fondazioneartet.it\/en\/2020\/02\/15\/venous-thromboembolism-prevention-and-treatment\/","title":{"rendered":"Venous thromboembolism: Prevention and Treatment"},"content":{"rendered":"<p><strong>Professor Anna Falanga<\/strong>\u00a0was interviewed by PharmaSTar during the <strong>Post-Orlando 2019 \u00a0meeting (News from the American Society for Hematology \u00a0\u2013 ASH)<\/strong>, held in Naples on 13-15 February 2020, where top Italian hematologists summarized the most important new findings presented at the meeting.\u00a0\u00a0 Professor Falanga, Head of the Immunohematology and Transfusion Medicine Department and the Hemostasis and Thrombosis Center at the Papa Giovanni XXIII Health Agency in Bergamo, spoke about one of the hottest topics on the ASH Congress agenda: prophylaxis, treatment of thrombosis, and the possibility of using increasingly low doses of anticoagulants, particularly the direct-action oral ones.\u00a0 She also dealt with the risk of thrombosis in cancer patients, with interesting data on the syndrome of antiphospholipid antibodies.<\/p>\n<p><iframe loading=\"lazy\" title=\"Tromboembolismo venoso, le novit\u00e0 del congresso americano su prevenzione e trattamento\" width=\"840\" height=\"473\" src=\"https:\/\/www.youtube.com\/embed\/6L-QPqGA65A?feature=oembed\" frameborder=\"0\" allow=\"accelerometer; autoplay; encrypted-media; gyroscope; picture-in-picture\" allowfullscreen><\/iframe><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Professor Anna Falanga\u00a0was interviewed by PharmaSTar during the Post-Orlando 2019 \u00a0meeting (News from the American Society for Hematology \u00a0\u2013 ASH), held in Naples on 13-15 February 2020, where top Italian hematologists summarized the most important new findings presented at the meeting.\u00a0\u00a0 Professor Falanga, Head of the Immunohematology and Transfusion Medicine Department and the Hemostasis and<\/p>\n","protected":false},"author":1,"featured_media":6571,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[150],"tags":[],"class_list":["post-6090","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news-en"],"acf":[],"_links":{"self":[{"href":"https:\/\/www.fondazioneartet.it\/en\/wp-json\/wp\/v2\/posts\/6090","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.fondazioneartet.it\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.fondazioneartet.it\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.fondazioneartet.it\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.fondazioneartet.it\/en\/wp-json\/wp\/v2\/comments?post=6090"}],"version-history":[{"count":3,"href":"https:\/\/www.fondazioneartet.it\/en\/wp-json\/wp\/v2\/posts\/6090\/revisions"}],"predecessor-version":[{"id":6374,"href":"https:\/\/www.fondazioneartet.it\/en\/wp-json\/wp\/v2\/posts\/6090\/revisions\/6374"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.fondazioneartet.it\/en\/wp-json\/wp\/v2\/media\/6571"}],"wp:attachment":[{"href":"https:\/\/www.fondazioneartet.it\/en\/wp-json\/wp\/v2\/media?parent=6090"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.fondazioneartet.it\/en\/wp-json\/wp\/v2\/categories?post=6090"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.fondazioneartet.it\/en\/wp-json\/wp\/v2\/tags?post=6090"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}